The role of NGAL as a biomarker for JSLE nephritis was first studied in 2006; uNGAL was shown to be higher in patients with JSLE than in positive controls with juvenile idiopathic arthritis (JIA), another chronic inflammatory rheumatic condition diagnosed in children, which is not associated with renal involvement [56]. Here, LCN2 is linked to juvenile idiopathic arthritis.